Mount Sinai
The study looked at Black patients with the APOL1 genotype, a signifier of increased risk of kidney failure.
In Brief This Week: Biodesix, Avisa Diagnostics, Mount Sinai, Sophia Genetics, and More
News items for the in vitro diagnostics industry for the week of Aug. 23, 2021.
Mount Sinai, Empire City Laboratories SARS-CoV-2 Tests Get FDA Emergency Use Authorizations
Mount Sinai's test uses self-collected saliva samples, while the two tests from Empire City Laboratories use self-collected anterior nasal swab specimens.
The genetic testing and health intelligence firm will start trading on the Nasdaq Global Select Market on Friday under the ticker symbols SMFR and SMFRW.
Bio-Techne expects the acquisition will provide it with a basis to build out its IVD presence, given Asuragen's diagnostic tests and regulatory expertise.